Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
China Isotope & Radiation Corp. ( (HK:1763) ) has shared an announcement.
China Isotope & Radiation Corporation announced the successful launch of the first batch of carbon-14 isotope products by its subsidiary, CNNC Qinshan Isotope Co., Ltd. This marks a significant milestone in China’s capability to independently produce and supply carbon-14 isotopes for commercial use, utilizing advanced technology with high efficiency and low waste. The development is expected to enhance the company’s market position and contribute to the high-quality development of the nuclear technology industry in China.
More about China Isotope & Radiation Corp.
China Isotope & Radiation Corporation (CIRC) operates in the nuclear technology industry, focusing on the production and supply of isotopes and related products. It is involved in the independent research, development, and market-oriented supply of isotopes, with a particular emphasis on advancing nuclear technology applications in alignment with national strategies.
Average Trading Volume: 274,675
Technical Sentiment Signal: Hold
Current Market Cap: HK$3.68B
For an in-depth examination of 1763 stock, go to TipRanks’ Stock Analysis page.